Five hours after injection of the 64Cu-labeled anti-CEA minibody, microPET imaging showed significantly higher uptake in the CEA-positive tumor (17.9 ± 3.8% ID/g) than the control C6 tumor (6.0 ± 1.0% ID/g). This evidence concerns the gene CEACAM5 and neoplasm.